These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 26225681)
1. Predictors of Participation in Prostate Cancer Screening among Older Men in Jordan. Abuadas MH; Petro-Nustas W; Albikawi ZF Asian Pac J Cancer Prev; 2015; 16(13):5377-83. PubMed ID: 26225681 [TBL] [Abstract][Full Text] [Related]
2. Factors associated with adherence to fecal occult blood testing for colorectal cancer screening among adults in the Republic of Korea. Bae N; Park S; Lim S Eur J Oncol Nurs; 2014 Feb; 18(1):72-7. PubMed ID: 24183583 [TBL] [Abstract][Full Text] [Related]
3. Prostate cancer screening practices in a large, integrated health system: 2007-2014. Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034 [TBL] [Abstract][Full Text] [Related]
4. Prostate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosure. Carey M; Bryant J; Yoong SL; Russell G; Barker D; Sanson-Fisher R BMC Fam Pract; 2013 Dec; 14():186. PubMed ID: 24321004 [TBL] [Abstract][Full Text] [Related]
5. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening. Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779 [TBL] [Abstract][Full Text] [Related]
6. Effects of an Educational Program for Prostate Cancer Prevention on knowledge and PSA Testing in Men Over 50 Years old in Community Areas of Shiraz in 2016. Molazem Z; Ebadi M; Khademian M; Zare R Asian Pac J Cancer Prev; 2018 Mar; 19(3):633-637. PubMed ID: 29580031 [TBL] [Abstract][Full Text] [Related]
7. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making]. Malli G Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936 [TBL] [Abstract][Full Text] [Related]
8. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions? O'Dell KJ; Volk RJ; Cass AR; Spann SJ J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074 [TBL] [Abstract][Full Text] [Related]
9. Predictors of prostate cancer screening among health fair participants. Chiu BC; Anderson JR; Corbin D Public Health; 2005 Aug; 119(8):686-93. PubMed ID: 15949522 [TBL] [Abstract][Full Text] [Related]
10. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault]. Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380 [TBL] [Abstract][Full Text] [Related]
11. Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland. Auvinen A; Tammela T; Stenman UH; Uusi-Erkkilä I; Leinonen J; Schröder FH; Hakama M Br J Cancer; 1996 Aug; 74(4):568-72. PubMed ID: 8761371 [TBL] [Abstract][Full Text] [Related]
12. Impact of PSA levels on second-round screening for the development of prostate cancer in men with low baseline PSA levels (≤2.0 mg/ml). Kitagawa Y; Sawada K; Urata S; Izumi K; Ueno S; Kadono Y; Konaka H; Mizokami A; Namiki M Anticancer Res; 2014 Nov; 34(11):6739-46. PubMed ID: 25368284 [TBL] [Abstract][Full Text] [Related]
13. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey. Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649 [TBL] [Abstract][Full Text] [Related]
14. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer. Hayat Roshanai A; Nordin K; Berglund G Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929 [TBL] [Abstract][Full Text] [Related]
15. Prostate cancer screening: Knowledge, attitudes and practices in a sample of men in Italy. A survey. Morlando M; Pelullo CP; Di Giuseppe G PLoS One; 2017; 12(10):e0186332. PubMed ID: 29023514 [TBL] [Abstract][Full Text] [Related]
16. Prevention and detection of prostate cancer: a pilot intervention in a resource--poor South African community. Matshela RF; Maree JE; van Belkum C Cancer Nurs; 2014; 37(3):189-97. PubMed ID: 23632472 [TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen testing: men's responses to 2012 recommendation against screening. Squiers LB; Bann CM; Dolina SE; Tzeng J; McCormack L; Kamerow D Am J Prev Med; 2013 Aug; 45(2):182-9. PubMed ID: 23867025 [TBL] [Abstract][Full Text] [Related]
18. GPs views and understanding of PSA testing, screening and early detection; survey. Sutton J; Melia J; Kirby M; Graffy J; Moss S Int J Clin Pract; 2016 May; 70(5):389-95. PubMed ID: 27121158 [TBL] [Abstract][Full Text] [Related]
19. Self-reported prevalence of prostate-specific antigen testing in South Australia: a community study. Pinnock CB; Weller DP; Marshall VR Med J Aust; 1998 Jul; 169(1):25-8. PubMed ID: 9695698 [TBL] [Abstract][Full Text] [Related]
20. Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial. Grenabo Bergdahl A; Wilderäng U; Aus G; Carlsson S; Damber JE; Frånlund M; Geterud K; Khatami A; Socratous A; Stranne J; Hellström M; Hugosson J Eur Urol; 2016 Oct; 70(4):566-573. PubMed ID: 26724840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]